MQ-710

N/A

Report date: 2025/12/15 20:00:38

Base Information

Drug NameMQ-710
Drug Alias NameMQ-710
ClassificationBiologics > Oncolytic virusVaccines > Application > Therapeutic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionFms-related tyrosine kinase 3 ligand modulatorsTumor necrosis factor ligand superfamily member 4 modulatorsGene transference
TargetsFms-related tyrosine kinase 3 ligandTumor necrosis factor ligand superfamily member 4
Therapy Area/IndicationsSolid tumoursNeoplasm MetastasisSquamous Cell Carcinoma of Head and Neck +[13] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMemorial Sloan Kettering Cancer CenterImvaq Therapeutics Corp
China Registration ClassN/A

Develop Information

Active CompaniesMemorial Sloan Kettering Cancer Center
Inactive CompaniesN/A
Active IndicationsSolid tumoursNeoplasm MetastasisSquamous Cell Carcinoma of Head and Neck +[12] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A